Spruce Biosciences, Inc.: shareholders and insiders

SPRBNASDAQHealthcare · Pharmaceutical Preparations

Price

$38.00

November 20, 2026Market cap $109M

What Ploutos Investor adds for Spruce Biosciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 23% since Nov 9, 2026, when the 10-Q these figures come from was filed ($49.34 then, $38.00 on Nov 20, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Jul 29, 2026, from their own Form 4 filings.

2 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

No trades under these filters.

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by SPRB's officers and directors from 2020 up to November 21, 2025, 6 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

5 Holders over 5%Aug 14, 2026 Latest filing
  • Orin Hirschmanwith 1 more person
    Share of class9.10%
  • BlackRock, Inc.
    Share of class6.80%
  • Boone Peter David MrCommon Stok, par value $0.0001
    Share of class6.40%
  • Integrated Core Strategies (US) LLCwith 3 more persons
    Share of class5.80%
  • AWM Investment Company, Inc.
    Share of class5.10%
Fell to 5% or less (14)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Citadel Advisors LLC1.90%Aug 14, 202613G/A
  • ADAR1 Capital Management, LLC2.50%Aug 14, 202613G/A
  • OrbiMed Advisors LLC4.80%Aug 14, 202613G
  • Squadron Master Fund LP0.90%May 15, 202613G/A
  • Wellington Management Group LLP3.60%May 15, 202613G/A
  • Alyeska Investment Group, L.P.4.49%May 15, 202613G/A
  • Ikarian Capital, LLC4.80%May 7, 202613G/A
  • ExodusPoint Capital Management, LP0.80%Apr 28, 202613G
  • The Carlyle Group Inc.13D4.70%Feb 18, 202613D/A
  • HealthCap VIII, L.P.13D3.40%Oct 9, 202513D/A
  • Radoff Family Foundation0.00%Aug 13, 202513G/A
  • Rock Springs Capital Management LP0.00%Aug 13, 202513G/A
  • Rosalind Advisors, Inc.0.00%Feb 13, 202513G/A
  • RiverVest Venture Fund III, L.P.13D4.20%Jan 10, 202513D/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter+57%
  • Citadel Advisors (Griffin)
    In the quarter+75%
  • Millennium Mgmt (Englander)
    In the quarter-15%
  • Renaissance Technologies
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 18.2% of its shares outstanding were held short, +21.0% since the report before.

Shares held short
522.1K
18.2%
Since the report before431.5K on Sep 30, 2026
+21.0%
6.6
78.8K
More days to cover thanof 4,578 US-listed companies with enough volume
75%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 35.4K
  • Nov 15, 2023: Shares held short 68.8K
  • Nov 30, 2023: Shares held short 52.3K
  • Dec 15, 2023: Shares held short 46.8K
  • Dec 29, 2023: Shares held short 77.0K
  • Jan 12, 2024: Shares held short 19.7K
  • Jan 31, 2024: Shares held short 42.9K
  • Feb 15, 2024: Shares held short 50.3K
  • Feb 29, 2024: Shares held short 33.7K
  • Mar 15, 2024: Shares held short 189.3K
  • Mar 28, 2024: Shares held short 320.4K
  • Apr 15, 2024: Shares held short 164.0K
  • Apr 30, 2024: Shares held short 215.5K
  • May 15, 2024: Shares held short 123.3K
  • May 31, 2024: Shares held short 40.3K
  • Jun 14, 2024: Shares held short 121.7K
  • Jun 28, 2024: Shares held short 248.1K
  • Jul 15, 2024: Shares held short 176.8K
  • Jul 31, 2024: Shares held short 135.0K
  • Aug 15, 2024: Shares held short 205.4K
  • Aug 30, 2024: Shares held short 252.1K
  • Sep 13, 2024: Shares held short 249.0K
  • Sep 30, 2024: Shares held short 359.9K
  • Oct 15, 2024: Shares held short 285.2K
  • Oct 31, 2024: Shares held short 232.8K
  • Nov 15, 2024: Shares held short 71.0K
  • Nov 29, 2024: Shares held short 30.7K
  • Dec 13, 2024: Shares held short 219.0K
  • Dec 31, 2024: Shares held short 107.1K
  • Jan 15, 2025: Shares held short 444.9K
  • Jan 31, 2025: Shares held short 246.6K
  • Feb 14, 2025: Shares held short 447.3K
  • Feb 28, 2025: Shares held short 425.1K
  • Mar 14, 2025: Shares held short 265.8K
  • Mar 31, 2025: Shares held short 136.4K
  • Apr 15, 2025: Shares held short 511.9K
  • Sep 15, 2025: Shares held short 618
  • Sep 30, 2025: Shares held short 5,658
  • Oct 15, 2025: Shares held short 20.5K
  • Oct 31, 2025: Shares held short 121.6K
  • Nov 14, 2025: Shares held short 86.9K
  • Nov 28, 2025: Shares held short 102.0K
  • Dec 15, 2025: Shares held short 88.1K
  • Dec 31, 2025: Shares held short 74.2K
  • Jan 15, 2026: Shares held short 61.2K
  • Jan 30, 2026: Shares held short 71.7K
  • Feb 13, 2026: Shares held short 77.9K
  • Feb 27, 2026: Shares held short 124.2K
  • Mar 13, 2026: Shares held short 136.5K
  • Mar 31, 2026: Shares held short 170.8K
  • Apr 15, 2026: Shares held short 180.5K
  • Apr 30, 2026: Shares held short 206.1K
  • May 15, 2026: Shares held short 215.1K
  • May 29, 2026: Shares held short 241.9K
  • Jun 15, 2026: Shares held short 262.6K
  • Jun 30, 2026: Shares held short 359.4K
  • Jul 15, 2026: Shares held short 415.9K
  • Jul 31, 2026: Shares held short 429.1K
  • Aug 14, 2026: Shares held short 403.0K
  • Aug 31, 2026: Shares held short 440.2K
  • Sep 15, 2026: Shares held short 416.1K
  • Sep 30, 2026: Shares held short 431.5K
  • Oct 15, 2026: Shares held short 522.1K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading62.3% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 62.3% of the shares in the reported trades were short sales, against 64.7% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
62.3%
The 14 beforeOct 14, 2026 – Nov 2, 2026
64.7%
Change
-2.4 pts
Short sales a dayon average, of 31.6K shares
19.7K
More than atof 3,666 US-listed companies, same days
87%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 73%
  • Oct 15, 2026: Short sales 71.2%
  • Oct 16, 2026: Short sales 57.6%
  • Oct 19, 2026: Short sales 62.7%
  • Oct 20, 2026: Short sales 63.7%
  • Oct 21, 2026: Short sales 77.1%
  • Oct 22, 2026: Short sales 71.3%
  • Oct 23, 2026: Short sales 55.6%
  • Oct 26, 2026: Short sales 54.9%
  • Oct 27, 2026: Short sales 75.2%
  • Oct 28, 2026: Short sales 69.2%
  • Oct 29, 2026: Short sales 61.8%
  • Oct 30, 2026: Short sales 64.7%
  • Nov 2, 2026: Short sales 50.4%
  • Nov 3, 2026: Short sales 30.2%
  • Nov 4, 2026: Short sales 51.5%
  • Nov 5, 2026: Short sales 87%
  • Nov 6, 2026: Short sales 70.2%
  • Nov 9, 2026: Short sales 63.3%
  • Nov 10, 2026: Short sales 69.7%
  • Nov 11, 2026: Short sales 48%
  • Nov 12, 2026: Short sales 79.5%
  • Nov 13, 2026: Short sales 68.6%
  • Nov 16, 2026: Short sales 76.3%
  • Nov 17, 2026: Short sales 66.2%
  • Nov 18, 2026: Short sales 56.6%
  • Nov 19, 2026: Short sales 65.9%
  • Nov 20, 2026: Short sales 56.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

2.57M Insiders' shares187.34% Of the company
  • Novo Holdings A/STenPercentOwner
    Directly2.55M
  • Javier B. SzwarcbergCHIEF EXECUTIVE OFFICER
    Directly19.3K
  • Parkman Healthcare Partners LLCTenPercentOwner
    Directly–

A lower bound: it counts only the 3 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

9 ETFs holding it0.03% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.03%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • DFACDimensional U.S. Core Equity 2 ETF
    Weight in the fund0.00%

9 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

64 Managers, Q2 2026$116M Value of their positions
  • Q3 2025: Managers 9
  • Q4 2025: Managers 32
  • Q1 2026: Managers 32
  • Q2 2026: Managers 64

Institutional investors by quarter

The fund managers holding SPRB, quarter by quarter, from Q4 2020 to Q2 2025, 19 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 64 managers held 2.15M shares, worth $116M. During the quarter 35 opened a position, 4 closed one, 15 added and 3 trimmed.

The largest holders, Q2 2026

  • AIGH Capital Management
    In the quarter
  • Orbimed Advisors
    In the quarter
  • BlackRock
    In the quarter×11.1
  • Millennium Mgmt (Englander)
    In the quarter+44%
  • AWM Investment
    In the quarter
  • Ikarian Capital
    In the quarter
  • Vanguard Capital Management
    In the quarter+551%
  • Alyeska Investment Group
    In the quarter+58%
  • Geode Capital Management
    In the quarter+447%
  • ADAR1 Capital Management
    In the quarter+16%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Spruce Biosciences's filings show?

Who buys and sells is one part of Spruce Biosciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SPRB's shareholders

Didn't find what you were looking for?

Ask us
Have SPRB's insiders bought or sold?

From Jul 9, 2026 to Jul 29, 2026 Spruce Biosciences's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold SPRB?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $6.6M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.